galantamine has been researched along with Neuroblastoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 6 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bottegoni, G; Cavalli, A; Daniele, S; Goldoni, L; Martini, C; Melchiorre, C; Piomelli, D; Pizzirani, D; Reggiani, A; Rosini, M; Simoni, E; Tarozzo, G; Trincavelli, ML | 1 |
| Jiang, N; Kong, LY; Li, SY; Sun, HB; Wang, KD; Wang, XB; Xie, SS; Yao, HQ | 1 |
| Celik Topkara, K; Cetinkaya, A; Demir, S; Kilinc, E; Saylan, A | 1 |
| Acar, OO; Deniz, FSS; Erdogan Orhan, I; Irmak, S; Luca, SV; Salmas, RE; Sen, A; Skalicka-Woźniak, K; Skiba, A; Tataringa, G; Turgut, GC; Zbancioc, AM | 1 |
| Currò, F; Kola, A; Lamponi, S; Valensin, D | 1 |
| Gao, F; Ji, WS; Lei, Y; Shan, LH; Wan, LX; Xiao, Y; Xu, JB; Zhang, Y; Zhou, XL | 1 |
| Girgin, M; Isik, S; Kantarci-Carsibasi, N | 1 |
| Atanasova, M; Doumanov, J; Doytchinova, I; Mladenova, K; Petrova, S; Philipova, I; Stavrakov, G | 1 |
| Aristizabal-Pachon, AF; Castillo, WO; de Lima Montaldi, AP; Sakamoto-Hojo, ET; Takahashi, CS | 1 |
| Egea, J; García, AG; López, MG; Romero, A | 1 |
| Li, Q; Wu, D; Zhang, L; Zhang, Y | 1 |
| Fang, J; Li, Q; Wu, D; Yang, M; Zhang, L; Zhang, Y | 1 |
| Alés, E; Arias, E; Cano-Abad, MF; Gabilan, NH; García, AG; López, MG; Villarroya, M | 1 |
| Barik, J; Dajas-Bailador, F; Wonnacott, S | 1 |
| Chen, HZ; Dong, CZ; Ezoulin, MJ; Heymans, F; Li, J; Massicot, F; Ombetta, JE; Wu, G | 1 |
| Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M | 1 |
| Govoni, S; Lanni, C; Lenzken, SC; Lucchelli, A; Racchi, M; Schettini, G | 1 |
17 other study(ies) available for galantamine and Neuroblastoma
| Article | Year |
|---|---|
Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cell Proliferation; Cerebral Cortex; Cholinesterase Inhibitors; Computer Simulation; Drug Combinations; Drug Design; Feasibility Studies; Galantamine; Humans; Male; Memantine; Neuroblastoma; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2012 |
Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Free Radical Scavengers; Humans; Mice; Neuroblastoma; Organometallic Compounds; Oxidation-Reduction; Peptide Fragments; Picrates; Structure-Activity Relationship; Tacrine | 2013 |
Therapeutic effects of carvacrol on beta-amyloid-induced impairments in in vitro and in vivo models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Galantamine; Hippocampus; Humans; Memory Disorders; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Rats; Superoxide Dismutase; Thymol | 2022 |
Evaluation of Anti-Alzheimer Activity of Synthetic Coumarins by Combination of in Vitro and in Silico Approaches.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Galantamine; Humans; Molecular Docking Simulation; Neuroblastoma; Structure-Activity Relationship | 2022 |
A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity.
Topics: Acetylcholinesterase; Alkaloids; Amyloid beta-Peptides; Cholinesterase Inhibitors; Galantamine; Humans; Neuroblastoma | 2023 |
Palladium-Catalyzed Synthesis, Acetylcholinesterase Inhibition, and Neuroprotective Activities of
Topics: Acetylcholinesterase; Alzheimer Disease; Catalysis; Cholinesterase Inhibitors; Galantamine; Humans; Hydrogen Peroxide; Molecular Docking Simulation; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Palladium; Structure-Activity Relationship | 2023 |
Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Molecular Docking Simulation; Neuroblastoma; Thiamine | 2023 |
A Galantamine-Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Antineoplastic Agents; Antioxidants; Cholinesterase Inhibitors; Curcumin; Cytoprotection; Galantamine; Humans; Neuroblastoma; Protective Agents; Tumor Cells, Cultured | 2021 |
Galanthamine decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell line.
Topics: Amyloid beta-Peptides; Analysis of Variance; Apoptosis; Cell Death; Cell Line, Tumor; Cell Proliferation; Cholinesterase Inhibitors; Colony-Forming Units Assay; Comet Assay; Cytokines; Dose-Response Relationship, Drug; Galantamine; Humans; Mitochondria; Neuroblastoma; Peptide Fragments | 2016 |
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.
Topics: Analysis of Variance; Cell Death; Cell Line, Tumor; Drug Synergism; Galantamine; Histocytochemistry; Humans; Mecamylamine; Melatonin; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Signal Transduction; Tryptamines | 2010 |
Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Differentiation; Cell Line, Tumor; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Galantamine; Humans; MAP Kinase Kinase Kinases; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Receptors, Nicotinic; Second Messenger Systems; Time Factors | 2010 |
Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcineurin; Calcineurin Inhibitors; Calpain; Cell Line, Tumor; Cholinesterase Inhibitors; Galantamine; Humans; Nerve Degeneration; Neuroblastoma; Peptide Fragments; Signal Transduction | 2010 |
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Apoptosis; Blotting, Western; Bungarotoxins; Calcium; Cattle; Cell Line, Tumor; Cholinesterase Inhibitors; Chromaffin Cells; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Fura-2; Galantamine; Humans; Immunohistochemistry; Neuroblastoma; Nicotine; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, Nicotinic; Thapsigargin | 2004 |
Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.
Topics: Binding Sites; Calcium; Cell Line, Tumor; Cell Membrane; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Humans; Neuroblastoma; Nicotine; Nicotinic Agonists; Potassium Chloride; Receptors, Nicotinic; Time Factors | 2005 |
Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Encephalitis; Furans; Galantamine; Glutathione; Humans; Inflammation Mediators; Interleukin-1; Lipopolysaccharides; Mitochondria; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Platelet Activating Factor; Reactive Oxygen Species | 2005 |
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine | 2005 |
Nicotinic component of galantamine in the regulation of amyloid precursor protein processing.
Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Brain Neoplasms; Cell Line, Tumor; Cholinesterase Inhibitors; Culture Media, Conditioned; Dose-Response Relationship, Drug; Galantamine; Humans; Neuroblastoma; Neurons; Receptors, Nicotinic | 2007 |